CMS is revamping its coverage with evidence development program with an eye to using its leverage more broadly to stimulate collection of clinical data where innovations do not neatly fit into coverage mandates.

Coverage with evidence development (CED) is a mechanism for CMS to grant conditional coverage contingent on some form of clinical data collection. CED typically restricts coverage to patients who are in a clinical trial, which is called "coverage with study participation."